Pigmented villonodular synovitis is an idiopathic overgrowth and pigmentation of the synovial membrane that most commonly affects the knee joint. It presents with pain, swelling, stiffness, and recurrent atraumatic hemorrhaging in the joint. Diagnosis is made through arthroscopic biopsy showing characteristic chocolate-colored lesions. Treatment involves surgical synovectomy or radiation therapy, with recurrence being a potential complication.
PVNS, also known as synovial xanthoma, involves idiopathic overgrowth of synovial membrane, mainly affecting the knee, associated with pigmented tumors.
Theories suggest an inflammatory response; involves CSF 1 gene mutation. Microscopic examination reveals yellowish-brown mass with specific characteristics.
Typically affects men 20-40 years old; may present asymptomatically or with joint pain, swelling, and recurrent hemarthrosis.
Diagnostic methods include normal ESR/CRP, arthroscopy, and imaging techniques like X-ray and MRI for joint assessment.
Treatment includes monitoring asymptomatic cases, medical options like Pexidartinib, and surgical interventions like synovectomy.
Risks include recurrence, joint destruction, skin necrosis, and potential for radiation-induced sarcoma.
⢠Also knownas synovial xanthoma or villous synovitis is an idiopathic
villous overgrowth and pigmentation of synovial membrane.
⢠Sites-MC Knee
⢠Other sites-Hip,ankle,shoulder,elbow,spine
ā¢
⢠Associated with GCT of tendon sheath(Pigmented villonodular tumor
of tendon sheath)
3.
⢠Jaffes theory-Inflammatoryresponse with the causative agent being
unknown.
⢠Overexpression of CSF 1 gene and mutation in chromosome 1p13 has
been said .
⢠Xanthoma cells are deriveD from reticuloendothelial system and are
modified to contain cholesterol.
⢠Colour is typically yellowish to yellowish brown due to cholesterol and
haemosiderin pigmentation.
Clinical features
⢠Usuallymen between 20-40 years get affected with/without previous history of trauma.
⢠Asymptomatic in some cases
⢠Insidious onset of pain,swelling ,limp, stiffness.
⢠Occasionally snapping and locking of the joint.
ā¢
⢠On examination effusion,joint line tenderness
ā¢
⢠Reccurent atraumatic haemarthrosis is the hallmark of this condition.
7.
Investigations
⢠1)ESR,CRP-Usually normal
ā¢
ā¢2)Other routine blood investigations.
⢠3) Diagnostic arthroscopy followed by biopsy.It is gold standard.
⢠4) Arthrocentesis/Joint aspiration-To see for orange brown colour
fluid containing cholesterol.
9.
Radiological
⢠1)X-ray ofthe affected joint-
⢠See for joint effusions,cystic lesions with sclerosis
⢠2)MRI
⢠Low intensity T1 and T2
⢠High intensity STIR(Short inversion T1 recovery)
⢠Blooming artifact-Signal loss because of iron in haemosiderin.
10.
Management
⢠Asymptomatic-Observe
⢠Medical-Pexidartinib(CSF1 receptor antagonist)
⢠Sold under brand name turalio
⢠Given for these patients with extensive disease who will not respond
to surgery
⢠Side effect-Hepatotoxicity,deranged enzymes,loss of hair,rash.
11.
⢠Intra Articularradiation-30-35 gy in 15 fractions Or 50 Gy in 25
fractions.
⢠Surgery-Arthroscopic synovectomy/Open synovectomy of the knee.